Top

Acta Neurochirurgica

Published in:

01-09-2015 | Clinical Article - Brain Tumors

Stereotactic Gamma Knife surgery safety and efficacy in the management of symptomatic benign confined cavernous sinus meningioma

Authors: Raef F. A. Hafez, Magad S. Morgan, Osama M. Fahmy

Published in: Acta Neurochirurgica | Issue 9/2015

Abstract

Background

Considering the proximity to cranial nerves from II to VI and the internal carotid artery microsurgery for cavernous sinus meningioma (CSM) has its limits of complete resection, with high potential tumor recurrences, cranial nerve and vascular morbidity. Gamma Knife surgery (GKS) is an advanced modality as primary treatment for patients harboring symptomatic benign confined CSM as well as adjuvant therapy to postoperative residual tumor giving a high rate of tumor control, stabilizing or even improving clinical condition with low morbidity.

Materials and methods

The aim of this study is to evaluate the safety and efficacy of GKS used in the management of 62 patients with symptomatic benign confined CSM < 3 cm in maximum diameters treated at the International Medical Centre (IMC), Cairo, Egypt, from 2005 to end of 2012, with mean follow-up period of 36 months (range, 24–96 months) by reviewing their clinical and radiological data. For 51 patients GKS was performed as a primary treatment. The diagnosis was based on typical clinical and imaging findings and in 11 patients GKS was used as adjuvant to post-operative tumor residual with histological confirmation.

Results

There were 43 females and 19 males. The median age at the time of treatment was 48 years. The mean tumor volume was 5.7 cc, the mean tumor marginal radiation dose was 14.4 Gy, the mean isodose line was 38 %, and the mean tumor coverage was 94.4 %. The optic pathway received < 8 Gy and the brain stem < 10 Gy. At most recent follow-up, 57 patients (92 %) had stable or improved cranial nerve deficits. Post-GKS cranial nerve complications were detected in five patients (8 %). Tumor volume was controlled in 60 patients (96 %) at most recent follow-up MRI; 12 patients had a reduction in tumor size and 42 had stable tumor size, while tumor size progression was detected in two patients. The tumor progression-free survival at 3 and 5 years in 40 patients who completed at least 5 years of follow-up was 95 %.

Conclusions

Gamma Knife surgery is a safe and effective option for the treatment of cavernous sinus meningioma not only as an adjuvant to surgery but also as an alternative to surgical removal in tumors confined mainly to the cavernous sinus.

Iwai Y, Yamanaka K, Ishiguro T (2003) Gamma Knife radiosurgery for the treatment of cavernous sinus meningiomas. Neurosurgery 52:517–524CrossRefPubMed

Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046–2056PubMed

Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL (2013) Single-fraction radiosurgery of benign cavernous sinus meningiomas. J Neurosurg 119:675–682CrossRefPubMed

Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, McDermott MW, Parsa AT (2010) Factors affecting outcome following treatment of patients with cavernous sinus meningiomas. J Neurosurg 113:1087–1092CrossRefPubMed

Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW (2008) Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 79:574–580CrossRefPubMed

De Jesus O, Sekhar LN, Parikh HK, Wright DC, Wagner DP (1996) Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence, progression, and quality of life. Neurosurgery 39:915–920CrossRefPubMed

Hayashi M, Chernov M, Tamura N, Tamura M, Horiba A, Konishi Y, Okada Y, Muragaki Y, Iseki H, Takakura K (2012) Gamma Knife radiosurgery for benign cavernous sinus tumors: treatment concept and outcomes in 120 cases. Neurol Med Chir (Tokyo) 52(10):714–23CrossRef

Lee JY, Niranjan A, McInerney J, Kondziolka D, Flickinger JC, Lunsford LD (2002) Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 97:65–72CrossRefPubMed

Couldwell WT, Kan P, Liu JK, Apfelbaum RI (2006) Decompression of cavernous sinus meningioma for preservation and improvement of cranial nerve function. J Neurosurg 105:148–152CrossRefPubMed

10.

Metellus P, Regis J, Muracciole X, Fuentes S, Dufour H, Nanni I, Chinot LO, Martin M, Grisoli F (2005) Evaluation of fractionated radiotherapy and Gamma Knife radiosurgery in cavernous sinus meningiomas: treatment strategy. Neurosurgery 57:873–886CrossRefPubMed

11.

Hasegawa T, Kida Y, Yoshimoto M, Koike J, Iizuka H, Ishii D (2007) Long-term outcomes of Gamma Knife surgery for cavernous sinus meningioma. J Neurosurg 107:745–751CrossRefPubMed

12.

Roche PH, Régis J, Dufour H, Fournier HD, Delsanti C, Pellet W, Grisoli F, Peragut JC (2000) Gamma Knife radiosurgery in the management of cavernous sinus meningiomas. J Neurosurg 93(Suppl 3):68–73PubMed

13.

Mathiesen T, Lindquist C, Kihlstrom L, Karlsson B (1996) Recurrence of cranial base meningiomas. Neurosurgery 39:2–9CrossRefPubMed

14.

Kano H, Park K, Iyer A, Niranjan A, Flickinger JC, Kondziolka D, Lunsford LD (2012) 184 cranial nerve function before and after stereotactic radiosurgery for cavernous sinus meningiomas: a twenty-three year assessment. Neurosurgery 71:571–572CrossRef

15.

Leber KA, Bergloff J, Pendl G (1998) Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88:43–50CrossRefPubMed

16.

Nicolato A, Foroni R, Alessandrini F, Bricolo A, Gerosa M (2002) Radiosurgical treatment of cavernous sinus meningiomas: experience with 122 treated patients. Neurosurgery 51:1153–1159CrossRefPubMed

17.

Maruyama K, Shin M, Kurita H, Kawahara N, Morita A, Kirino T (2004) Proposed treatment strategy for cavernous sinus meningiomas: a prospective study. Neurosurgery 55:1068–1075CrossRefPubMed

Title: Stereotactic Gamma Knife surgery safety and efficacy in the management of symptomatic benign confined cavernous sinus meningioma
Authors: Raef F. A. Hafez
Magad S. Morgan
Osama M. Fahmy
Publication date: 01-09-2015
Publisher: Springer Vienna
Published in: Acta Neurochirurgica / Issue 9/2015
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-015-2509-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Stereotactic Gamma Knife surgery safety and efficacy in the management of symptomatic benign confined cavernous sinus meningioma

Abstract

Background

Materials and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2015

Retrospective feasibility analysis of modified posterior partial vertebrectomy with 360-degree decompression in destructive thoracic spondylodiscitis

Anterior thalamic nucleus deep brain Stimulation (DBS) for drug-resistant complex partial seizures (CPS) with or without generalization: long-term evaluation and predictive outcome

Call for uniform neuropsychological assessment after aneurysmal subarachnoid hemorrhage: Swiss recommendations

Spontaneous subarachnoid hemorrhage and negative initial vascular imaging—should further investigation depend upon the pattern of hemorrhage on the presenting CT?

A single thalamic target for deep brain stimulation to treat hemi-body pain syndrome

Anterior cervical discectomy and fusion versus posterior cervical foraminotomy in the treatment of brachialgia: the Leeds spinal unit experience (2008–2013)